Re: 3 Weeks To The 31st

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: 3 Weeks To The 31st

in response to

Re: 3 Weeks To The 31st

SanFrancisco99

posted on Mar 15, 2017 09:21AM

As of today, we are now 9 months since first dosing in the single agent ZEN-3694 trial and 3 months since they initiated the ZEN-3694/enzalutamide combo trial. The suspense is building......

3 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply